IBSA GROUP
IBSA Austria
IBSA Baltic
IBSA Belgium
IBSA China
IBSA Czechia
IBSA France
IBSA Germany
IBSA Hong Kong
IBSA Hungary
IBSA Iberia
IBSA Italy
IBSA Netherlands
IBSA Nordic
IBSA Poland
IBSA Singapore
IBSA Slovakia
IBSA Switzerland
IBSA Turkey
IBSA UK
IBSA USA
Media
Careers
IBSA GROUP
IBSA Austria
IBSA Baltic
IBSA Belgium
IBSA China
IBSA Czechia
IBSA France
IBSA Germany
IBSA Hong Kong
IBSA Hungary
IBSA Iberia
IBSA Italy
IBSA Netherlands
IBSA Nordic
IBSA Poland
IBSA Singapore
IBSA Slovakia
IBSA Switzerland
IBSA Turkey
IBSA UK
IBSA USA
EN
IT
About Us
Governance & Management
Inside IBSA
Technologies
Production Sites
IBSA Derma
Our Pillars
Person
Innovation
Quality
Responsibility
Therapeutic areas
Reproductive Medicine
Endocrinology
Pain and Inflammation
Osteoarticular
Aesthetic Medicine
Dermatology
Uro-gynaecology
Cardiometabolic
Respiratory
Consumer Health
Sustainability
Our Manifesto for Sustainability
Our Sustainability Report
#IBSA2030
40 Anniversary
The dream
hIBStory
The voices of IBSA
The value of sustainability
Science for All
Creating Tomorrow
IBSA Foundation
About Us
Governance & Management
Inside IBSA
Technologies
Production Sites
IBSA Derma
Our Pillars
Person
Innovation
Quality
Responsibility
Therapeutic areas
Reproductive Medicine
Endocrinology
Pain and Inflammation
Osteoarticular
Aesthetic Medicine
Dermatology
Uro-gynaecology
Cardiometabolic
Respiratory
Consumer Health
Sustainability
Our Manifesto for Sustainability
Our Sustainability Report
#IBSA2030
40 Anniversary
The dream
hIBStory
The voices of IBSA
The value of sustainability
Science for All
Creating Tomorrow
IBSA Foundation
Media
Careers
EN
IT
2024
FATTURATO E PERSONE:
894 milioni di CHF
2617 persone
Back to top
